FDA Warns Bayer About Testing At German Plant

Law360, New York (September 16, 2009, 7:37 PM EDT) -- The U.S. Food and Drug Administration has warned Bayer AG to tighten its testing and quality monitoring procedures at a German facility, issuing a letter advising the company to amend its standards to comply with the agency's good manufacturing practices.

The FDA released a warning letter Sept. 15 sent to the manager of a Bayer supply center in Bergkamen, Germany, on Aug. 5 after an eight-day agency investigation of the plant in March turned up “significant deviations” from the agency's accepted standards for the manufacturing of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.